Discovery of Aroyl Piperazine Derivatives as IKr & IKs Dual Inhibitors for Cardiac Arrhythmia Treatment

Author(s): Xiaoke Guo, Haopeng Sun, Lvpei Du, Lu Huang, Jing Xu, Yingying Zhu, Peng Yu, Xiaojin Zhang, Yiqun Tang, Qidong You.

Journal Name: Medicinal Chemistry

Volume 10 , Issue 5 , 2014

Become EABM
Become Reviewer

Graphical Abstract:


Combined blockade of IKr and IKs potassium channels is considered to be a promising therapeutic strategy for arrhythmia. In this study, we designed and synthesized 15 derivatives through modifying the hit compound 7 that was discovered by screening in-house database by whole-patch clamp technique. All of the compounds were evaluated on CHO and HEK 293 cell lines stably expressing hERG (IKr) and hKCNQ1/KCNE1 (IKs) potassium channels, and half of them exhibited improved dual IKr and IKs inhibitory effects compared to the hit compound. Compounds 7a and 7b with potent dual inhibitory activities were selected for further in vivo evaluations. Due to the preferable pharmacological behaviors, compound 7a deserved further optimization as a promising lead compound.

Keywords: IKr and IKs dual inhibitor, arrhythmia, class III antiarrhythmic agents.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2014
Page: [497 - 505]
Pages: 9
DOI: 10.2174/1573406409666131128144755
Price: $65

Article Metrics

PDF: 29